Free Trial

Moleculin Biotech (MBRX) Institutional Ownership

Moleculin Biotech logo
$2.45
-0.15 (-5.77%)
(As of 11/1/2024 ET)

Institutional Ownership Changes (13F Filings) for Moleculin Biotech (NASDAQ:MBRX)

Current
Institutional Ownership
Percentage
15.52%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$41.97M
Number of
Institutional Sellers
(last 12 months)
0
Get MBRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Moleculin Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

MBRX Institutional Buying and Selling by Quarter

Moleculin Biotech Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2024Armistice Capital LLC156,000$549K0.0%+5.1%6.747%
2/13/2024Armistice Capital LLC3,207,417$2.75M0.0%N/A9.600%
1/17/2024 Atticus Wealth Management LLC50,001$43K0.0%N/A0.168%
5/15/2023Sio Capital Management LLC1,010,956$971K0.5%-2.5%3.407%
7/25/2022 Walker Asset Management LLC20,708$32K0.0%N/A0.072%
4/20/2022Sigma Planning Corp57,500$102K0.0%+33.7%0.201%
2/2/2022Sigma Planning Corp43,000$80K0.0%N/A0.150%
11/9/2021BlackRock Inc.270,402$812K0.0%-2.5%0.947%
9/17/2021Virtu Financial LLC25,302$93K0.0%N/A0.089%
8/16/2021Occudo Quantitative Strategies LP29,188$107K0.0%+31.7%0.102%
8/16/2021State Street Corp59,900$220K0.0%N/A0.210%
8/13/2021Geode Capital Management LLC237,586$871K0.0%+35.9%0.835%
8/13/2021Vanguard Group Inc.1,047,529$3.84M0.0%+123.6%3.683%
8/12/2021XTX Topco Ltd32,997$121K0.0%N/A0.116%
8/5/2021GSA Capital Partners LLP31,120$114K0.0%N/A0.109%
5/21/2021Citadel Advisors LLC13,843$56K0.0%N/A0.049%
5/19/2021Squarepoint Ops LLC28,904$118K0.0%+134.2%0.102%
5/18/2021Cubist Systematic Strategies LLC26,624$109K0.0%N/A0.094%
5/18/2021Citadel Advisors LLC13,843$56K0.0%N/A0.049%
5/14/2021Occudo Quantitative Strategies LP22,158$90K0.0%N/A0.078%
5/12/2021Northern Trust Corp50,731$207K0.0%-43.1%0.178%
5/12/2021Geode Capital Management LLC174,822$713K0.0%-40.6%0.615%
5/7/2021BlackRock Inc.239,326$977K0.0%+449.7%0.841%
4/27/2021 Harel Insurance Investments & Financial Services Ltd.10,000$136K0.0%N/A0.035%
4/14/2021Taylor Cottrill Erickson & Associates Inc.16,964$69K0.0%-83.3%0.060%
2/10/2021Renaissance Technologies LLC948,503$756K0.0%+6.4%7.901%
11/13/2020Truist Financial Corp175,000$142K0.0%+25.0%0.284%
(Data available from 1/1/2016 forward)

MBRX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of MBRX shares?

During the previous two years, the following institutional investors and hedge funds held shares of Moleculin Biotech shares: Sio Capital Management LLC ($971K), and Armistice Capital LLC ($549K), Atticus Wealth Management LLC ($43K).Learn more on MBRX's institutional investors.

What percentage of Moleculin Biotech stock is owned by institutional investors?

15.52% of Moleculin Biotech stock is owned by institutional investors. Learn more on MBRX's institutional investor holdings.

Which institutional investors have been buying Moleculin Biotech stock?

The following institutional investors have purchased Moleculin Biotech stock in the last 24 months: Armistice Capital LLC ($3.21M), and Atticus Wealth Management LLC ($50.00K).

How much institutional buying is happening at Moleculin Biotech?

Institutional investors have bought a total of 3,264,923 shares in the last 24 months. This purchase volume represents approximately $41.97M in transactions.

Which Moleculin Biotech major shareholders have been selling company stock?

The following institutional investors have sold Moleculin Biotech stock in the last 24 months: Sio Capital Management LLC ($25.90K).

How much institutional selling is happening at Moleculin Biotech?

Institutional investors have sold a total of 25,897 shares in the last 24 months. This volume of shares sold represents approximately $372.92K in transactions.



This page (NASDAQ:MBRX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners